Pfizer (PFE) Wheel Strategy Research
By Terrell K. Flautt — 20 years investing and swing trading, 5 years trading options
Published
Terrell is not a licensed financial advisor. Nickelpie publishes educational analysis, not investment advice.
| Price | $25.09 | Today | +$0.27 (+1.09%) |
| 52-week range | $23.11 – $28.75 | Position in range | 35% |
| 100 shares cost | $2,509 | Dividend yield | 6.93% |
Where Pfizer trades right now
As of July 16, 2026, Pfizer (PFE) trades at $25.09, up about 1% on the day, in the lower-middle of a tight one-year range of $23.11 to $28.75. It yields roughly 6.9%. At this price, 100 shares cost about $2,500. The combination of a narrow range, deep liquidity, and a big dividend is exactly the calm, boring profile the wheel prefers — with one asterisk worth taking seriously.
What that big yield is telling you
A ~6.9% dividend on a large-cap pharma stock is unusually high, and unusually high yields are rarely generosity — they're the market pricing in doubt. In Pfizer's case the doubts are concrete: patent expirations on key drugs and the steep normalization of COVID-era revenue that once inflated earnings. This is the same lesson the wheel teaches about premium: the fatter the payout, the more carefully you should ask what risk you're being paid to accept.
Support levels worth watching
Reference levels from the one-year range and round numbers — confirm on a chart:
- ~$24 — a round number just below the current price and the nearest area to watch.
- ~$23 — round-number support sitting right at the 52-week low.
- $23.11 — the 52-week low itself; a decisive break below would be a real signal.
A cash-secured put a wheel seller might study
Applying the wheel framework — a cash-secured put near 0.25–0.30 delta, 21–45 days out, at a strike you'd be content owning at — the $24 strike sits just below the current price (about 4% down; $2,400 collateral), and the $23 strike lines up with the 52-week low for a more conservative entry ($2,300collateral).
If assigned, you'd own a high-yielding defensive name near its lows, collect the dividend while you hold, and sell covered calls above your basis — a textbook wheel setup, provided you've made peace with the dividend risk. Model any strike and premium with the wheel calculator, and confirm live numbers on your chain.
The honest risk picture
The core risks are the patent cliff and pipeline dependence: pharma earnings can step down sharply as blockbuster drugs lose exclusivity, and the replacements aren't guaranteed. Add post-pandemic revenue normalization, drug-pricing and regulatory pressure, and the dividend question above. The tight trading range makes Pfizer feel safe, and it is calmer than most — but "calm" and "no risk" aren't the same thing. Wheel it only if you'd be genuinely content holding it through a down leg.
Position disclosure. As of publication, Nickelpie and its principals do not hold a position in PFE. We hold positions in other securities. No one compensates us for covering PFE. See our full position disclosure. This analysis is drawn from public information and is educational only — it is not investment advice or a recommendation. Do your own research and consider your own situation and risk tolerance.
Common questions
Is Pfizer (PFE) a good stock for the wheel strategy?
It fits a defensive, income-oriented wheel: ~$25 means 100 shares cost about $2,500, options are liquid, and it trades in a tight range with a large ~6.9% dividend. The caution is whythe yield is so high — patent cliffs and post-COVID revenue normalization. A fat yield, like a fat option premium, is often a warning, not a gift.
What put strike could a wheel seller consider on Pfizer?
With PFE near $25.09 and a 52-week low of $23.11, a seller wanting an entry near support might study the $24 strike (~4% below) or the $23 strike (near the low). Collateral is $2,400or $2,300. Verify the delta and premium on your live chain.
Is Pfizer’s ~6.9% dividend safe?
No dividend is guaranteed, and a yield that high usually signals market doubt. Pfizer generates real cash, but patent cliffs and the fall in pandemic-era revenue pressure the earnings that fund it. Treat the dividend as a bonus if assigned, not a reason to oversize the position.
More wheel research
- Ford Motor Company (F)At ~$14 with a $10.68–$17.78 range, Ford is one of the most affordable liquid wheel candidates — ~$1,400 per contract.
- AT&T (T)A ~5.2% dividend and a steady $19.89–$29.79 range make AT&T a classic income-oriented wheel name at ~$2,200 per contract.
- eBay (EBAY)A cash-generative, lower-volatility marketplace near its highs — a quality wheel name, but ~$11,000 per contract puts it out of small-account range.
- GameStop (GME)Huge cash pile, elevated implied volatility, and a ~$2,200 contract — GME pays fat premium, and that premium is a warning as much as an opportunity.
- Archer Aviation (ACHR)Pre-revenue eVTOL at fresh 52-week lows near $4.57. Very affordable and premium-rich — because the market prices real bankruptcy/dilution risk.
- Infleqtion (INFQ)Newly public quantum-computing pure-play down ~37% YTD near $8.95. Big cash pile, big cash burn, and a premium that reflects the risk.
- Amprius Technologies (AMPX)Silicon-anode battery maker near $10 after a sharp drop. Real orders, real cash burn — a high-volatility speculative name, not an income wheel.
- Sidus Space (SIDU)A ~$175M space micro-cap near $2 with a $0.63–$6.79 range. Debt cleared, but options are thin and the risk is extreme — for tiny speculative sizing only.
Before trading options, read the OCC's Characteristics and Risks of Standardized Options. Past performance does not predict future results.